≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Other/unspecified site

DOID EFO MESH SNOMED PheWeb

CD2_BENIGN_NOS

benign neoplasm: A neoplasm which is characterized by the absence of morphologic features associated with malignancy (severe cytologic atypia, tumor cell necrosis, and high mitotic rate). Benign neoplasms remain confined to the original site of growth and do not metastasize to other anatomic sites.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D36.7&, D36.9&
Hospital discharge: ICD-9 2298B|2899
Hospital discharge: ICD-8 2289
Cause of death: ICD-10 D36.7&, D36.9&
Cause of death: ICD-9 2298B|2899
Cause of death: ICD-8 2289

428

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

382

diagram downward connector

Check minimum number of events None

382

diagram downward connector

Include endpoints None

382

diagram downward connector
CD2_BENIGN_NOS

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 382 215 167
Unadjusted prevalence (%) 0.11 0.11 0.11
Mean age at first event (years) 47.89 44.98 51.62

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.57 [0.28, 1.16] 1.2e-1 42
15 years 0.00 0.36 [0.16, 0.83] 1.7e-2 16
5 years 0.00 1.36 [0.60, 3.07] 4.6e-1 13
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_NOS – Benign neoplasm: Other/unspecified site
GWS hits:

Survival analyses between endpoints

↥

Plot

before Benign neoplasm: Other/unspecified site
after Benign neoplasm: Other/unspecified site

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Benign neoplasm: Other/unspecified site

↥